Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	malate dehydrogenase (decarboxylating) (NADP+) activity	ME1 ME2 ME3	3.29e-08	3	65	3	GO:0004473
GeneOntologyMolecularFunction	malic enzyme activity	ME1 ME2 ME3	1.31e-07	4	65	3	GO:0004470
GeneOntologyMolecularFunction	oxaloacetate decarboxylase activity	ME1 ME2 ME3	1.31e-07	4	65	3	GO:0008948
GeneOntologyMolecularFunction	malate dehydrogenase activity	ME1 ME2 ME3	1.82e-06	8	65	3	GO:0016615
GeneOntologyMolecularFunction	carboxy-lyase activity	ODC1 ME1 ME2 ME3	5.57e-06	36	65	4	GO:0016831
GeneOntologyMolecularFunction	lyase activity	ODC1 CA5B ME1 ME2 CA2 ME3 CA5A	5.69e-06	212	65	7	GO:0016829
GeneOntologyMolecularFunction	malate dehydrogenase (decarboxylating) (NAD+) activity	ME1 ME2	1.04e-05	2	65	2	GO:0004471
GeneOntologyMolecularFunction	carbonate dehydratase activity	CA5B CA2 CA5A	1.79e-05	16	65	3	GO:0004089
GeneOntologyMolecularFunction	carbon-carbon lyase activity	ODC1 ME1 ME2 ME3	3.31e-05	56	65	4	GO:0016830
GeneOntologyMolecularFunction	hydro-lyase activity	CA5B CA2 CA5A	1.14e-03	63	65	3	GO:0016836
GeneOntologyMolecularFunction	MHC class I receptor activity	KIR3DL1 KIR3DS1	1.54e-03	18	65	2	GO:0032393
GeneOntologyMolecularFunction	NAD binding	ME1 ME2 ME3	1.74e-03	73	65	3	GO:0051287
GeneOntologyMolecularFunction	immune receptor activity	ACKR3 KIR3DL1 KIR3DS1 CRLF2	2.06e-03	165	65	4	GO:0140375
GeneOntologyMolecularFunction	carbon-oxygen lyase activity	CA5B CA2 CA5A	2.43e-03	82	65	3	GO:0016835
GeneOntologyBiologicalProcess	malate metabolic process	ME1 ME2 ME3	2.48e-06	9	65	3	GO:0006108
Domain	ig	NPHS1 GP6 SDK2 PTPRD PTPRS LILRA6 SIGLEC11 KIR3DL1 ADAMTSL3 KIR3DS1	1.40e-09	190	67	10	PF00047
Domain	Immunoglobulin	NPHS1 GP6 SDK2 PTPRD PTPRS LILRA6 SIGLEC11 KIR3DL1 ADAMTSL3 KIR3DS1	1.40e-09	190	67	10	IPR013151
Domain	Malic_OxRdtase	ME1 ME2 ME3	4.41e-08	3	67	3	IPR001891
Domain	Malic_NAD-bd	ME1 ME2 ME3	4.41e-08	3	67	3	IPR012302
Domain	Malic_N_dom	ME1 ME2 ME3	4.41e-08	3	67	3	IPR012301
Domain	MALIC_ENZYMES	ME1 ME2 ME3	4.41e-08	3	67	3	PS00331
Domain	Malic_M	ME1 ME2 ME3	4.41e-08	3	67	3	PF03949
Domain	Malic_M	ME1 ME2 ME3	4.41e-08	3	67	3	SM00919
Domain	malic	ME1 ME2 ME3	4.41e-08	3	67	3	PF00390
Domain	-	ME1 ME2 ME3	4.41e-08	3	67	3	3.40.50.10380
Domain	malic	ME1 ME2 ME3	4.41e-08	3	67	3	SM01274
Domain	Malic_enzyme_CS	ME1 ME2 ME3	4.41e-08	3	67	3	IPR015884
Domain	Ig-like_fold	NPHS1 GP6 ILDR2 SDK2 PTPRD TRIM42 PTPRS LILRA6 ASTN2 SIGLEC11 KIR3DL1 ADAMTSL3 KIR3DS1 CRLF2	1.63e-07	706	67	14	IPR013783
Domain	IG	NPHS1 GP6 ILDR2 SDK2 PTPRD PTPRS LILRA6 SIGLEC11 KIR3DL1 ADAMTSL3 KIR3DS1	2.77e-07	421	67	11	SM00409
Domain	Ig_sub	NPHS1 GP6 ILDR2 SDK2 PTPRD PTPRS LILRA6 SIGLEC11 KIR3DL1 ADAMTSL3 KIR3DS1	2.77e-07	421	67	11	IPR003599
Domain	-	NPHS1 GP6 ILDR2 SDK2 PTPRD TRIM42 PTPRS ASTN2 SIGLEC11 KIR3DL1 ADAMTSL3 KIR3DS1 CRLF2	5.49e-07	663	67	13	2.60.40.10
Domain	Ig-like_dom	NPHS1 GP6 ILDR2 SDK2 PTPRD PTPRS LILRA6 SIGLEC11 KIR3DL1 ADAMTSL3 KIR3DS1	1.59e-06	503	67	11	IPR007110
Domain	FN3	NPHS1 SDK2 PTPRD TRIM42 PTPRS ASTN2 CRLF2	4.40e-06	185	67	7	SM00060
Domain	FN3	NPHS1 SDK2 PTPRD TRIM42 PTPRS ASTN2 CRLF2	7.10e-06	199	67	7	PS50853
Domain	IG_LIKE	NPHS1 GP6 ILDR2 SDK2 PTPRD PTPRS LILRA6 SIGLEC11 KIR3DL1 ADAMTSL3	9.31e-06	491	67	10	PS50835
Domain	Carbonic_anhydrase_a-class_CS	CA5B CA2 CA5A	9.49e-06	12	67	3	IPR018338
Domain	FN3_dom	NPHS1 SDK2 PTPRD TRIM42 PTPRS ASTN2 CRLF2	9.78e-06	209	67	7	IPR003961
Domain	CA-VB_mt	CA5B CA5A	1.27e-05	2	67	2	IPR018437
Domain	Carbonic_anhydrase_a-class	CA5B CA2 CA5A	1.95e-05	15	67	3	IPR023561
Domain	ALPHA_CA_1	CA5B CA2 CA5A	1.95e-05	15	67	3	PS00162
Domain	IGc2	NPHS1 GP6 SDK2 PTPRD PTPRS SIGLEC11 ADAMTSL3	2.09e-05	235	67	7	SM00408
Domain	Ig_sub2	NPHS1 GP6 SDK2 PTPRD PTPRS SIGLEC11 ADAMTSL3	2.09e-05	235	67	7	IPR003598
Domain	ALPHA_CA_2	CA5B CA2 CA5A	2.89e-05	17	67	3	PS51144
Domain	Carb_anhydrase	CA5B CA2 CA5A	2.89e-05	17	67	3	PF00194
Domain	Carb_anhydrase	CA5B CA2 CA5A	2.89e-05	17	67	3	SM01057
Domain	-	CA5B CA2 CA5A	2.89e-05	17	67	3	3.10.200.10
Domain	Carbonic_anhydrase_a	CA5B CA2 CA5A	2.89e-05	17	67	3	IPR001148
Domain	Ig_I-set	NPHS1 SDK2 PTPRD PTPRS SIGLEC11 ADAMTSL3	6.11e-05	190	67	6	IPR013098
Domain	I-set	NPHS1 SDK2 PTPRD PTPRS SIGLEC11 ADAMTSL3	6.11e-05	190	67	6	PF07679
Domain	fn3	NPHS1 SDK2 PTPRD TRIM42 PTPRS	2.89e-04	162	67	5	PF00041
Domain	PLAC	PCSK6 ADAMTSL3	1.12e-03	14	67	2	PF08686
Domain	PLAC	PCSK6 ADAMTSL3	2.08e-03	19	67	2	PS50900
Domain	PLAC	PCSK6 ADAMTSL3	2.08e-03	19	67	2	IPR010909
Domain	RHO	RND3 RND1	2.31e-03	20	67	2	PS51420
Domain	TYR_PHOSPHATASE_dom	PTPRD SBF1 PTPRS	3.77e-03	87	67	3	IPR000387
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA5B CA2 CA5A	1.27e-05	12	56	3	M671
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA5B CA2 CA5A	1.27e-05	12	56	3	MM14574
Pathway	KEGG_PYRUVATE_METABOLISM	ACSS1 ME1 ME2 ME3	1.83e-05	40	56	4	M7934
Pathway	KEGG_NITROGEN_METABOLISM	CA5B CA2 CA5A	9.94e-05	23	56	3	M4629
Pathway	WP_TCA_CYCLE_IN_SENESCENCE	ME1 ME2	6.83e-04	10	56	2	M40058
Pathway	REACTOME_PYRUVATE_METABOLISM	ME1 ME2 ME3	7.01e-04	44	56	3	MM15393
Pubmed	A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system.	CA5B CA2 CA5A	1.48e-06	12	67	3	17362527
Pubmed	A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	23524032
Pubmed	MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta.	PTPRD MTSS1	3.66e-06	2	67	2	12570871
Pubmed	Cloning and functional characterization of the 5' flanking region of the human mitochondrial malic enzyme gene. Regulatory role of Sp1 and AP-2.	ME1 ME2	3.66e-06	2	67	2	11358520
Pubmed	Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	30365992
Pubmed	No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	19874556
Pubmed	Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines.	CA5B CA5A	3.66e-06	2	67	2	17174092
Pubmed	Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	17182560
Pubmed	Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	27708262
Pubmed	Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both enzymes in ammonia detoxification and glucose metabolism.	CA5B CA5A	3.66e-06	2	67	2	23589845
Pubmed	Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	19008943
Pubmed	Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4.	PTPRD MTSS1	3.66e-06	2	67	2	15684034
Pubmed	Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	18331531
Pubmed	Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	16805919
Pubmed	HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	19386717
Pubmed	Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.	ME1 ME3	3.66e-06	2	67	2	33619771
Pubmed	Functional roles of the tetramer organization of malic enzyme.	ME1 ME3	3.66e-06	2	67	2	19416979
Pubmed	State-of-the-art computational methods to predict protein-protein interactions with high accuracy and coverage.	ME2 ME3	3.66e-06	2	67	2	37401192
Pubmed	Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	19211742
Pubmed	Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	28942035
Pubmed	The profile of KIR3DL1 and KIR3DS1 alleles in an African American population resembles that found in African populations.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	20230527
Pubmed	Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.	CLEC9A CLEC12A	3.66e-06	2	67	2	27978488
Pubmed	Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	35192601
Pubmed	Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	11098931
Pubmed	Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosis.	HABP2 F5	3.66e-06	2	67	2	12578864
Pubmed	Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	37647275
Pubmed	Association of the KIR3DS1013 and KIR3DL1004 alleles with susceptibility to ankylosing spondylitis.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	20131260
Pubmed	Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	25112829
Pubmed	Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.	CA5B CA5A	3.66e-06	2	67	2	22109883
Pubmed	Purification and properties of cytosolic and mitochondrial malic enzyme isolated from human brain.	ME1 ME2	3.66e-06	2	67	2	7757881
Pubmed	Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	17694054
Pubmed	Molecular mechanism for the regulation of human mitochondrial NAD(P)+-dependent malic enzyme by ATP and fumarate.	ME1 ME2	3.66e-06	2	67	2	12121650
Pubmed	Mitochondrial malic enzyme (E.C.1.1.1.40) in human leukocytes: formal genetics and population genetics.	ME2 ME3	3.66e-06	2	67	2	511162
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	3.66e-06	2	67	2	9566880
Pubmed	Expression of Malic Enzymes in Sebaceous Lesions.	ME1 ME2	3.66e-06	2	67	2	26381116
Pubmed	Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis.	CA5B CA5A	3.66e-06	2	67	2	26913920
Pubmed	Metastasis suppressor 1 interacts with protein tyrosine phosphatase receptor-δ to regulate adipogenesis.	PTPRD MTSS1	3.66e-06	2	67	2	36906292
Pubmed	Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	19411600
Pubmed	Different regulatory properties of the cytosolic and mitochondrial forms of malic enzyme isolated from human brain.	ME1 ME2	3.66e-06	2	67	2	7496989
Pubmed	Contribution of functional KIR3DL1 to ankylosing spondylitis.	KIR3DL1 KIR3DS1	3.66e-06	2	67	2	20818412
Pubmed	Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease.	CA5B CA5A	3.66e-06	2	67	2	36464834
Pubmed	Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles.	CA5B CA5A	3.66e-06	2	67	2	10677517
Pubmed	Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium.	ILDR2 TRIM42 CLSTN2	6.48e-06	19	67	3	25367360
Pubmed	An analysis of expression patterns of genes encoding proteins with catalytic activities.	ACSS1 CA5B CA2 CA5A	8.80e-06	67	67	4	17626619
Pubmed	A systematic survey of carbonic anhydrase mRNA expression during mammalian inner ear development.	CA5B CA2 CA5A	1.03e-05	22	67	3	23233153
Pubmed	Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals.	KIR3DL1 KIR3DS1	1.10e-05	3	67	2	12826375
Pubmed	A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion.	RND3 RND1	1.10e-05	3	67	2	9531558
Pubmed	KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.	KIR3DL1 KIR3DS1	1.10e-05	3	67	2	24059286
Pubmed	Endocytosed factor V is trafficked to CD42b+ proplatelet extensions during differentiation of human umbilical cord blood-derived megakaryocytes.	CD34 F5	1.10e-05	3	67	2	29761851
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRS	1.10e-05	3	67	2	31985401
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRS	1.10e-05	3	67	2	20139422
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRS	1.10e-05	3	67	2	9784606
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRS	1.10e-05	3	67	2	33656439
Pubmed	Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence.	ME1 ME2	1.10e-05	3	67	2	23334421
Pubmed	Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family.	CA2 CA5A	1.10e-05	3	67	2	14600151
Pubmed	Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.	KIR3DL1 KIR3DS1	1.10e-05	3	67	2	11859120
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	1.10e-05	3	67	2	25394468
Pubmed	KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.	KIR3DL1 KIR3DS1	1.10e-05	3	67	2	19859704
Pubmed	Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies.	KIR3DL1 KIR3DS1	1.10e-05	3	67	2	17301953
Pubmed	Differences in the gestational pattern of mRNA expression of the Rnd family in rat and human myometria.	RND3 RND1	1.10e-05	3	67	2	16311049
Pubmed	Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.	PTPRD MTSS1	1.10e-05	3	67	2	25287652
Pubmed	Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.	KIR3DL1 KIR3DS1	1.10e-05	3	67	2	19019897
Pubmed	Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform.	PTPRD PTPRS KIR3DL1	1.72e-05	26	67	3	36178190
Pubmed	The human plasma proteome: a nonredundant list developed by combination of four separate sources.	CD34 HABP2 F5 ITIH2 CA2	1.72e-05	165	67	5	14718574
Pubmed	Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1.	CDK16 CDK14	2.19e-05	4	67	2	19524571
Pubmed	Expression profile of KIR3DS1/KIR3DL1 receptors in association with immunological responses in TB, HIV and HIV/TB infected patients.	KIR3DL1 KIR3DS1	2.19e-05	4	67	2	37169313
Pubmed	Activating KIR genes are associated with ankylosing spondylitis in Asian populations.	KIR3DL1 KIR3DS1	2.19e-05	4	67	2	18638658
Pubmed	Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.	KIR3DL1 KIR3DS1	2.19e-05	4	67	2	27455421
Pubmed	Socius is a novel Rnd GTPase-interacting protein involved in disassembly of actin stress fibers.	RND3 RND1	2.19e-05	4	67	2	11940653
Pubmed	Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.	GP6 F5	2.19e-05	4	67	2	19278955
Pubmed	Polymorphism and domain variability of human killer cell inhibitory receptors.	KIR3DL1 KIR3DS1	2.19e-05	4	67	2	9059894
Pubmed	Development of glomerular endothelial cells, podocytes and mesangial cells in the human fetus and infant.	NPHS1 CD34	2.19e-05	4	67	2	17464107
Pubmed	The RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain.	RND3 RND1	2.19e-05	4	67	2	20811643
Pubmed	High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.	KIR3DL1 KIR3DS1	2.19e-05	4	67	2	19522772
Pubmed	The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.	PTPRD PTPRS	2.19e-05	4	67	2	8524829
Pubmed	The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated.	KIR3DL1 KIR3DS1	2.19e-05	4	67	2	15580659
Pubmed	Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation.	RND3 RND1	2.19e-05	4	67	2	22357615
Pubmed	Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.	CLEC9A CLEC12A	2.19e-05	4	67	2	21677141
Pubmed	Chromodomain helicase binding protein 8 (Chd8) is a novel A-kinase anchoring protein expressed during rat cardiac development.	AKAP6 AKAP13	3.64e-05	5	67	2	23071553
Pubmed	Multilocus genomic mapping with intracisternal A-particle proviral oligonucleotide probes hybridized to mouse DNA in dried agarose gels.	ME1 CA2	3.64e-05	5	67	2	7774558
Pubmed	Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.	PTPRD PTPRS	3.64e-05	5	67	2	10777529
Pubmed	Human carbonic anhydrases and carbonic anhydrase deficiencies.	CA5B CA2	3.64e-05	5	67	2	7574487
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.	KIR3DL1 KIR3DS1	3.64e-05	5	67	2	16508981
Pubmed	Bicellular Localization of Tricellular Junctional Protein Angulin-3/ILDR2 Allows Detection of Podocyte Injury.	NPHS1 ILDR2	3.64e-05	5	67	2	38311119
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRD PTPRS	3.64e-05	5	67	2	22357843
Pubmed	Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins.	RND3 RND1	3.64e-05	5	67	2	29040270
Pubmed	Rnd proteins function as RhoA antagonists by activating p190 RhoGAP.	RND3 RND1	3.64e-05	5	67	2	12842009
Pubmed	Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes.	KIR3DL1 KIR3DS1	3.64e-05	5	67	2	17990989
Pubmed	Specification of neural circuit architecture shaped by context-dependent patterned LAR-RPTP microexons.	PTPRD PTPRS	5.46e-05	6	67	2	38388459
Pubmed	Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases.	PTPRD PTPRS	5.46e-05	6	67	2	19273906
Pubmed	Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta.	PTPRD PTPRS	5.46e-05	6	67	2	16738228
Pubmed	Identification of splicing variants of Rapostlin, a novel RND2 effector that interacts with neural Wiskott-Aldrich syndrome protein and induces neurite branching.	RND3 RND1	5.46e-05	6	67	2	14732713
Pubmed	Receptor protein tyrosine phosphatases are novel components of a polycystin complex.	PTPRD PTPRS	5.46e-05	6	67	2	21126580
Pubmed	Use of two-dimensional electrophoresis to identify and map new mouse genes.	ME1 CA2	5.46e-05	6	67	2	447069
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.	KIR3DL1 KIR3DS1	5.46e-05	6	67	2	20528243
Pubmed	The AXB and BXA set of recombinant inbred mouse strains.	ME1 CA2	5.46e-05	6	67	2	1477475
Pubmed	Modulation of apoptotic response by LAR family phosphatases-cIAP1 signaling during urinary tract morphogenesis.	PTPRD PTPRS	7.63e-05	7	67	2	29073098
Pubmed	The GTPase-deficient Rnd proteins are stabilized by their effectors.	RND3 RND1	7.63e-05	7	67	2	22807448
Pubmed	Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.	PTPRD PTPRS	7.63e-05	7	67	2	12376545
Pubmed	Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases.	PTPRD PTPRS	7.63e-05	7	67	2	23345436
Cytoband	19q13.4	GP6 LILRA6 KIR3DL1 KIR3DS1	5.73e-06	79	67	4	19q13.4
Cytoband	22q13	PIM3 MIEF1	6.67e-04	26	67	2	22q13
Cytoband	Ensembl 112 genes in cytogenetic band chr1q24	ILDR2 PRRX1 F5	9.10e-04	129	67	3	chr1q24
Cytoband	5p13.2	NADK2 WDR70	9.49e-04	31	67	2	5p13.2
Cytoband	3q23	TRIM42 CLSTN2	1.91e-03	44	67	2	3q23
Cytoband	12p13.2	CLEC9A CLEC12A	1.99e-03	45	67	2	12p13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr3q23	TRIM42 CLSTN2	3.87e-03	63	67	2	chr3q23
Cytoband	2q37.3	KLHL30 ACKR3	5.72e-03	77	67	2	2q37.3
Cytoband	Ensembl 112 genes in cytogenetic band chrXp22	OFD1 CA5B CRLF2	5.91e-03	250	67	3	chrXp22
GeneFamily	Fibronectin type III domain containing	NPHS1 SDK2 PTPRD TRIM42 PTPRS ASTN2 CRLF2	2.70e-07	160	50	7	555
GeneFamily	Carbonic anhydrases	CA5B CA2 CA5A	1.58e-05	18	50	3	460
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SDK2 PTPRD PTPRS SIGLEC11 ADAMTSL3	8.07e-05	161	50	5	593
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR3DL1 KIR3DS1	1.11e-03	18	50	2	620
GeneFamily	Rho family GTPases	RND3 RND1	1.38e-03	20	50	2	390
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRS	1.52e-03	21	50	2	813
GeneFamily	Immunoglobulin like domain containing	NPHS1 GP6 SDK2 ADAMTSL3	1.98e-03	193	50	4	594
GeneFamily	Cyclin dependent kinases	CDK16 CDK14	2.33e-03	26	50	2	496
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP6 AKAP13	2.90e-03	29	50	2	396
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CLEC9A CD34 LILRA6 KIR3DL1 CLEC12A	4.54e-03	394	50	5	471
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	NPHS1 SIGLEC11	5.47e-03	40	50	2	592
GeneFamily	C-type lectin domain family	CLEC9A CLEC12A	7.48e-03	47	50	2	494
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	TRIM42 AKAP13	8.77e-03	51	50	2	870
Coexpression	GSE3982_DC_VS_NKCELL_DN	AKAP6 PTPRD ACKR3 CD34 PMEL KIR3DL1	1.14e-05	197	67	6	M5480
Coexpression	GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	AKAP6 LPIN2 ASTN2 HABP2 PMEL KHSRP	1.21e-05	199	67	6	M8111
Coexpression	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	RND1 PTPRD ACKR3 CD34 MTSS1 AKAP13 ADAMTSL3 ME1	1.31e-05	427	67	8	M17923
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	CDK16 MYOF RND1 PTPRD SBF1 PTPRS CDK14 ADAMTSL3	4.38e-05	506	67	8	M253
Coexpression	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	CD34 PCSK6 F5 ME3	5.33e-05	80	67	4	M14275
Coexpression	MOOTHA_GLUCONEOGENESIS	ME1 ME2 ME3	6.82e-05	31	67	3	M13448
CoexpressionAtlas	EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05	RND3 ILDR2 PRRX1 SDK2 RND1 PTPRS PMEL CA2	1.01e-05	345	65	8	PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5	PTPRD PTPRS ACKR3 ACSS1 PCSK6 ZNF780B LPIN2 ASTN2 CLSTN2 ZNF692 FHIP2B	1.43e-05	743	65	11	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	RND3 ILDR2 PRRX1 SDK2 PTPRD ARRDC1 ACKR3 ACSS1 LPIN2 ASTN2 CLSTN2 ME1	3.89e-05	986	65	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3	PTPRD SBF1 ACKR3 ACSS1 PCSK6 ZNF780B LPIN2 ASTN2 CLSTN2 ZNF692	7.02e-05	730	65	10	Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#1	PTPRD ACKR3 ACSS1 ZNF780B ASTN2 CLSTN2	7.87e-05	233	65	6	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2	PTPRD ACKR3 ACSS1 PCSK6 ZNF780B LPIN2 ASTN2 AKAP13 CLSTN2 ME1	8.50e-05	747	65	10	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	ILDR2 MYOF SDK2 RND1 PTPRD SBF1 MTSS1 LPIN2 PMEL CDK14 ZNF692 ME3	8.92e-05	1075	65	12	PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
CoexpressionAtlas	Myeloid Cells, DC.8+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	RND3 CLEC9A CDK14 CLEC12A	9.15e-05	77	65	4	GSM605827_100
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4	PTPRD ACKR3 ACSS1 ASTN2 CLSTN2 ME1	1.08e-04	247	65	6	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	ILDR2 ZSWIM8 MYOF SDK2 PTPRD SBF1 MTSS1 LPIN2 ODC1 PMEL ZNF692 FHIP2B CA2 ME3	1.14e-04	1466	65	14	PCBC_ratio_ECTO_vs_SC_cfr-2X-p05
CoexpressionAtlas	Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3	RND3 CLEC9A CD34 CLEC12A	1.17e-04	82	65	4	GSM791114_100
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3	MYOF CLEC9A CDK14 CLEC12A	1.17e-04	82	65	4	GSM538231_100
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_1000	NPHS1 ILDR2 ACKR3 LPIN2	1.34e-04	85	65	4	gudmap_developingKidney_e15.5_Podocyte cells_1000_k2
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000	MYOF MASP1 PRRX1 SDK2 PTPRD ACKR3 ACSS1 ZNF780B ASTN2 CLSTN2 ME1	1.55e-04	967	65	11	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000	MYOF PRRX1 SDK2 CLEC9A PTPRD ACKR3 ACSS1 ASTN2 CLSTN2 ME1 CA2	1.56e-04	968	65	11	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_200	NPHS1 ILDR2 MYOF MTSS1 LPIN2	2.21e-04	179	65	5	gudmap_kidney_adult_Podocyte_MafB_200
CoexpressionAtlas	DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#2_top-relative-expression-ranked_500	NPHS1 ILDR2 ARRDC1 ACKR3 LPIN2	2.64e-04	186	65	5	gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k2
CoexpressionAtlas	DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#2_top-relative-expression-ranked_1000	NPHS1 ILDR2 ARRDC1 ACKR3 LPIN2	2.77e-04	188	65	5	gudmap_developingKidney_e15.5_S-shaped body_1000_k2
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_500	PRRX1 PTPRD CLSTN2	2.89e-04	42	65	3	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k5
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	RND3 ZSWIM8 MYOF MASP1 RND1 PCSK6 HABP2 ODC1 CDK14 ITIH2 CA2	3.13e-04	1049	65	11	PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4	PTPRD ACKR3 ACSS1 PCSK6 ZNF780B LPIN2 ASTN2 CLSTN2 ZNF692	3.33e-04	721	65	9	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5	PTPRD ACKR3 ACSS1 PCSK6 ZNF780B LPIN2 ASTN2 AKAP13 CLSTN2	3.36e-04	722	65	9	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_500	NPHS1 ILDR2 MYOF ACKR3 MTSS1 LPIN2 ASTN2	4.13e-04	445	65	7	gudmap_kidney_adult_Podocyte_MafB_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_1000	ILDR2 OFD1 PCSK6 CLSTN2	4.57e-04	117	65	4	gudmap_developingGonad_e18.5_ovary_1000_k3
CoexpressionAtlas	kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_200	NPHS1 ILDR2 MTSS1 LPIN2	5.36e-04	122	65	4	gudmap_kidney_adult_Podocyte_MafB_k1_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	RND3 ACKR3 ACSS1 LPIN2 ASTN2 CLSTN2	5.93e-04	339	65	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4	PTPRD ACKR3 ACSS1 ASTN2 CLSTN2	6.05e-04	223	65	5	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_1000	NPHS1 ILDR2 MYOF MTSS1 LPIN2	6.55e-04	227	65	5	gudmap_kidney_adult_RenCorpuscGlomer_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000	MYOF PRRX1 SDK2 PTPRD ARRDC1 ACKR3 ACSS1 ASTN2 CLSTN2 ME1	6.72e-04	967	65	10	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	MPP2 RND3 ILDR2 ZSWIM8 SDK2 RND1 LPIN2 PMEL CDK14 ME3	6.72e-04	967	65	10	PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000	AKAP6 MASP1 PRRX1 KLHL30 NADK2 ACSS1 F5 ITIH2 CA2	7.38e-04	805	65	9	gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000
CoexpressionAtlas	kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000	ACKR3 MINK1 LPIN2	7.49e-04	58	65	3	gudmap_kidney_P0_CapMes_Crym_k4_1000
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 MASP1 CLSTN2 F5 MGAT4C	1.30e-07	158	66	6	e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 MASP1 CLSTN2 F5 MGAT4C	1.30e-07	158	66	6	d39e020c3e77eb9d3de600a171d22f94357061d4
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ILDR2 ACKR3 CD34 PCSK6 ADAMTSL3 ITIH2	2.81e-07	180	66	6	c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 MYOF CLSTN2 F5 MGAT4C	3.63e-07	188	66	6	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 MYOF CLSTN2 F5 MGAT4C	3.63e-07	188	66	6	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF SDK2 PTPRD PTPRS ASTN2 CDK14	3.74e-07	189	66	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ILDR2 PRRX1 ACKR3 CD34 PCSK6 ADAMTSL3	4.63e-07	196	66	6	ed6047b48b6a96baa6a90c7af784e7c34b32824d
ToppCell	metastatic_Brain-T/NK_cells-Naive_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	PTPRD PEX5 ME2 CA5A TRIM60	2.65e-06	147	66	5	4f7a0c287721befeffabf95b8c5f9ff64149c7c1
ToppCell	390C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MASP1 CLEC9A PMEL KIR3DL1 CLEC12A	3.12e-06	152	66	5	ebce79e106bf1d84241f8dd3496ff1771f9666be
ToppCell	390C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MASP1 CLEC9A PMEL KIR3DL1 CLEC12A	3.12e-06	152	66	5	4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CDK16 ZSWIM8 ZNF780B KIR3DL1 ME1	3.32e-06	154	66	5	ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad
ToppCell	facs-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PCSK6 HABP2 F5 ITIH2	3.54e-06	156	66	5	e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLHL30 NADK2 MIEF1 SIGLEC11 TBCC	4.01e-06	160	66	5	8374ae912337947b2cc8d17d5840f306361fe1ff
ToppCell	3'_v3-bone_marrow-Myeloid_Mac-Macrophage\|bone_marrow / Manually curated celltypes from each tissue	RND3 ACKR3 ME1 CA2 ME3	6.73e-06	178	66	5	11a338032b59b936c5e65517c4160f7dd47a2cda
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 CD34 PCSK6 ASTN2	7.70e-06	183	66	5	5cfcd589a480e67654d3d94e71916f122150db10
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 CD34 PCSK6 ASTN2	7.70e-06	183	66	5	c3ea8d3b916ffcaca3156e0d77a952724554c4ab
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 CD34 PCSK6 ASTN2	7.70e-06	183	66	5	81003ddc24164959dd41bb12fcac72638789b8f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD MTSS1 F5	7.70e-06	183	66	5	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD MTSS1 F5	7.70e-06	183	66	5	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	control-Others\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	GP6 CD34 PCSK6 ODC1 CA2	7.91e-06	184	66	5	a63b39fcc570b554cf10e8e47c2c1e079034768f
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	PRRX1 PTPRS CD34 CLSTN2 ADAMTSL3	7.91e-06	184	66	5	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD MTSS1 F5	7.91e-06	184	66	5	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PTPRD ACSS1 HABP2 ME1	8.12e-06	185	66	5	3e3217c99719fd1d2fa94e16be7712a7e5077152
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PTPRD ACSS1 HABP2 ME1	8.12e-06	185	66	5	0ff4148b4701003d9d594e0da8261176fb13aa59
ToppCell	PBMC-Control-Hematopoietic\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GP6 CD34 PCSK6 ODC1 CA2	8.12e-06	185	66	5	c95c77d4302d7fff7fdef1774f15a93ba9ced61a
ToppCell	PBMC-Control-Hematopoietic\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	GP6 CD34 PCSK6 ODC1 CA2	8.12e-06	185	66	5	72a281ef246de5b30de1241d792c25bfae60e797
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MPP2 PRRX1 ACKR3 CD34 CLSTN2	8.78e-06	188	66	5	e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 PTPRS ACKR3 CD34 CLSTN2	9.01e-06	189	66	5	d531399749409d614adca13d181830c6e3287508
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RND3 MYOF SDK2 PTPRD CDK14	9.24e-06	190	66	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	PTPRD PTPRS PCSK6 CLSTN2 ADAMTSL3	9.48e-06	191	66	5	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ILDR2 MYOF ACKR3 CD34 PCSK6	9.72e-06	192	66	5	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RND3 MYOF SDK2 PTPRD CDK14	9.72e-06	192	66	5	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RND3 MYOF SDK2 PTPRD CDK14	9.72e-06	192	66	5	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	facs-Aorta-Heart-3m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 MYOF PRRX1 PTPRS PCSK6	9.72e-06	192	66	5	0dc1f46e40346ed0b286e53b106a812441575100
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRS ACKR3 CD34 CLSTN2 ADAMTSL3	9.97e-06	193	66	5	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ILDR2 ACKR3 CD34 PCSK6 ADAMTSL3	1.02e-05	194	66	5	7b6ec45adb7ece3c8a7b78c5782413b5825effe2
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 ACKR3 CD34 PCSK6	1.02e-05	194	66	5	0e315c63407fa00643722a7d6138b1502f79b10d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RND3 MYOF SDK2 PTPRD CDK14	1.02e-05	194	66	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 ACKR3 CD34 PCSK6	1.02e-05	194	66	5	588c45dafa00547b2506e298a2434b1b5e15560d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 F5 MGAT4C ITIH2	1.02e-05	194	66	5	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 ACKR3 CD34 PCSK6	1.02e-05	194	66	5	c2990d6eda3954dc01913bf3910df79f06e0010a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MPP2 PRRX1 PTPRS CLSTN2 ADAMTSL3	1.05e-05	195	66	5	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	Mesenchymal_cells-Endosteal_fibro.\|World / Lineage and Cell class	PRRX1 ACKR3 CD34 PCSK6 ADAMTSL3	1.05e-05	195	66	5	d53974d1866e23c894ffd492ea11d20422919b11
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 PRRX1 PTPRD CD34 ADAMTSL3	1.07e-05	196	66	5	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 PRRX1 PTPRD CD34 ADAMTSL3	1.07e-05	196	66	5	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	facs-Trachea\|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RND3 PRRX1 PCSK6 ODC1 ADAMTSL3	1.07e-05	196	66	5	8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCell	facs-Trachea\|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 PRRX1 PCSK6 ODC1 ADAMTSL3	1.07e-05	196	66	5	34020d6553309daa269dff05de0a8567211ea4d2
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 MYOF PRRX1 PTPRS PCSK6	1.07e-05	196	66	5	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 F5 MGAT4C ITIH2	1.07e-05	196	66	5	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RND3 MYOF SIGLEC11 ME1 ME2	1.13e-05	198	66	5	9aaff68107ae4542f904b142d23669f2fcd557ac
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RND3 MYOF SIGLEC11 ME1 ME2	1.13e-05	198	66	5	5aaf3861c53763cf09bb628c9d2eabb6a7277021
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOF CLSTN2 F5 MGAT4C ITIH2	1.16e-05	199	66	5	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.16e-05	199	66	5	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Transverse-Macrophage-LYVE1_Macrophage\|Transverse / Region, Cell class and subclass	MYOF LILRA6 SIGLEC11 ME1 ME3	1.16e-05	199	66	5	facf79c256db5ae57bdb613e86ec90616a6f67ca
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	RND3 MYOF SIGLEC11 ME1 ME2	1.16e-05	199	66	5	78db2e3b85356ed2f08794e5a97c16a220f8a076
ToppCell	Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage\|Transverse / shred on region, Cell_type, and subtype	MYOF LILRA6 SIGLEC11 ME1 ME3	1.16e-05	199	66	5	dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOF CLSTN2 F5 MGAT4C ITIH2	1.16e-05	199	66	5	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.16e-05	199	66	5	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Control-Control-Others\|Control / Disease, condition lineage and cell class	GP6 CD34 PCSK6 ODC1 CA2	1.16e-05	199	66	5	b7e83772fdd466e1bd0ae13af9ac477e7595ae14
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.16e-05	199	66	5	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac\|lymph-node_spleen / Manually curated celltypes from each tissue	RND3 MYOF SIGLEC11 ME1 ME2	1.16e-05	199	66	5	c051cc3e42cfa2ec09fd8dae1172af350bb2dfcb
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RND3 PRRX1 ACKR3 CLSTN2 ADAMTSL3	1.18e-05	200	66	5	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.18e-05	200	66	5	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.18e-05	200	66	5	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.18e-05	200	66	5	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.18e-05	200	66	5	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RND3 MYOF SDK2 PTPRD CDK14	1.18e-05	200	66	5	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 PTPRS CD34 CLSTN2 ADAMTSL3	1.18e-05	200	66	5	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 ACKR3 CD34 CLSTN2 ADAMTSL3	1.18e-05	200	66	5	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MASP1 PCSK6 GLRA3 MGAT4C	3.15e-05	121	66	4	056d0f0f7a4d1b2d38b83647bbe4468b7c959ce6
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SDK2 CD34 MGAT4C ME3	4.17e-05	130	66	4	05d5a73acf1d7f75a79876b1a06d27c74a89b8a4
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PCSK6 HABP2 ITIH2	5.42e-05	139	66	4	82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PCSK6 HABP2 ITIH2	5.42e-05	139	66	4	fc9ac09c2106e88104a52575832d71d17765eec8
ToppCell	facs-Liver-Hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PCSK6 HABP2 ITIH2	5.42e-05	139	66	4	fc4b39ac9a10cf0acacfebbc4295edf324d930d5
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PCSK6 HABP2 ITIH2	5.42e-05	139	66	4	4ddfbc36a0560fb70594627178bff652ab1ea3e9
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MASP1 PCSK6 GLRA3 MGAT4C	6.74e-05	147	66	4	50e86860a94be103092c40e39a172eac92372f0d
ToppCell	facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 MYOF LILRA6 CLEC12A	8.07e-05	154	66	4	1e088b0d4a44267f46a9b643f46a1aba784686b1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD TBCC	9.13e-05	159	66	4	fd7db2f7328cfefdc3ada2af91006d5a91d137e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD TBCC	9.13e-05	159	66	4	aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD TBCC	9.13e-05	159	66	4	8bbdef1e927f3130b578d7d7c5ff38bbe06fab63
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MASP1 PCSK6 GLRA3 MGAT4C	9.35e-05	160	66	4	0bfdaf979e6f128cba2928ce16bca4d3deff8ac9
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PCSK6 ME1 F5	9.35e-05	160	66	4	c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCell	(1)_Control_(PBS)-(4)_COL2.3+_osteoblasts\|(1)_Control_(PBS) / Stress and Cell class	PTPRS CD34 ME2 CLEC12A	9.35e-05	160	66	4	8450466fc2465c56798df2b520edd23c2c2e941c
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 MYOF LILRA6 CLEC12A	9.35e-05	160	66	4	1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RND3 ACKR3 MTSS1 F5	1.00e-04	163	66	4	ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8
ToppCell	facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GP6 MYOF LILRA6 F5	1.05e-04	165	66	4	ab6ed7e30096c418e7be2d5eec33feeddd1387d9
ToppCell	367C-Fibroblasts-Fibroblast-F\|367C / Donor, Lineage, Cell class and subclass (all cells)	PRRX1 CD34 PCSK6 ADAMTSL3	1.08e-04	166	66	4	2887f4f0c218cbcbcc82eef27aa4ee714b35cddb
ToppCell	droplet-Spleen-nan-3m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 CLEC9A CDK14 CLEC12A	1.08e-04	166	66	4	c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3
ToppCell	367C-Fibroblasts-Fibroblast-F-\|367C / Donor, Lineage, Cell class and subclass (all cells)	PRRX1 CD34 PCSK6 ADAMTSL3	1.08e-04	166	66	4	1cc291a04f4144abba4aca7badeb7776db05d903
ToppCell	droplet-Spleen-nan-3m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 CLEC9A CDK14 CLEC12A	1.08e-04	166	66	4	94c30d6ca179d0cb02a5ed0093c5a2871e17ae50
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD F5	1.13e-04	168	66	4	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD F5	1.13e-04	168	66	4	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ILDR2 PTPRD F5	1.13e-04	168	66	4	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 CD34 PCSK6	1.15e-04	169	66	4	bb43abad2c049b7f4d307737347290e01b3339a3
ToppCell	droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND3 CLEC9A PTPRS CLEC12A	1.15e-04	169	66	4	7962165cab84af73d20b56eb70b1ed87c94025ef
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 CD34 PCSK6	1.15e-04	169	66	4	5f18e3f40a5b1b167903f37516ec8181e889c7c5
ToppCell	facs-GAT-Fat-18m-Myeloid-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC9A LILRA6 CRLF2 CLEC12A	1.15e-04	169	66	4	7a7416fcbffcf57d19b477d9da091e04e3499524
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ILDR2 PRRX1 CD34 PCSK6	1.15e-04	169	66	4	8bfa2d3bb541d02f55d7c95b8fd156c8403befca
ToppCell	facs-GAT-Fat-18m-Myeloid\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC9A LILRA6 CRLF2 CLEC12A	1.15e-04	169	66	4	0e1a99cd77edcf32bcb513abd247b2b27409ac63
ToppCell	facs-GAT-Fat-18m-Myeloid-myeloid_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC9A LILRA6 CRLF2 CLEC12A	1.15e-04	169	66	4	9bbad31ef03078f5aa456f2e1b17b49c91545ff0
Drug	Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	MPP2 CD34 TTLL5 PCSK6 MINK1 CDK14 ADAMTSL3 F5 ITIH2	5.72e-09	198	66	9	3891_UP
Drug	Meta Vanadate	ME1 ME2 ME3	1.93e-06	9	66	3	CID000445092
Drug	beta-sulfinylpyruvate	ME1 ME2 ME3	3.78e-06	11	66	3	CID000000110
Drug	D-402	ME1 ME2 ME3	3.78e-06	11	66	3	CID005744486
Drug	Skl tripeptide	PEX5 ME1 ME2 ME3	6.63e-06	42	66	4	CID000131223
Drug	Tartronate	ME2 ME3	8.28e-06	2	66	2	DB03680
Drug	zonisamide	CA5B CA2 CA5A	8.28e-06	14	66	3	ctd:C022189
Drug	CO(2	CLSTN2 ODC1 CA5B ME1 ME2 CA2 ME3 CA5A	1.33e-05	378	66	8	CID000000280
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	MASP1 RND1 PCSK6 AKAP13 CA5B KHSRP	1.66e-05	186	66	6	4463_UP
Drug	carbamoyl phosphate	SBF1 ODC1 CA5B CA2 CA5A	1.93e-05	113	66	5	CID000000278
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; HL60; HT_HG-U133A	NPHS1 MYOF CD34 TTLL5 PCSK6 KHSRP	2.17e-05	195	66	6	2940_UP
Drug	sulthiame	CA5B CA2 CA5A	2.18e-05	19	66	3	CID000005356
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	MPP2 MYOF SBF1 PCSK6 MINK1 AKAP13	2.23e-05	196	66	6	2198_DN
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; MCF7; HT_HG-U133A	GP6 RND1 PCSK6 MINK1 CDK14 ITIH2	2.23e-05	196	66	6	2280_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; PC3; HT_HG-U133A	NPHS1 HABP2 PMEL F5 ITIH2 CA2	2.29e-05	197	66	6	5765_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	AKAP6 CD34 TTLL5 MINK1 HABP2 F5	2.36e-05	198	66	6	4816_UP
Drug	Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	NPHS1 MYOF MASP1 LPIN2 PEX5 CA5B	2.36e-05	198	66	6	4351_UP
Drug	Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; HL60; HT_HG-U133A	GP6 PCSK6 MINK1 ZNF780B ASTN2 ME3	2.36e-05	198	66	6	2727_UP
Drug	Proglumide [6620-60-6]; Up 200; 12uM; PC3; HT_HG-U133A	GP6 ZSWIM8 CD34 TTLL5 GLRA3 CA5B	2.43e-05	199	66	6	4337_UP
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; HL60; HT_HG-U133A	GP6 PTPRS MINK1 ASTN2 CLSTN2 CA5B	2.43e-05	199	66	6	2483_UP
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MYOF CD34 TTLL5 PEX5 AKAP13 CLSTN2	2.43e-05	199	66	6	2243_DN
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ZSWIM8 TTLL5 PCSK6 MINK1 PEX5 KHSRP	2.43e-05	199	66	6	5421_DN
Drug	ethylene dichloride	RND3 PIM3 SDK2 PTPRD WDR70 LPIN2 AKAP13 ODC1 ME1	2.44e-05	539	66	9	ctd:C024565
Drug	4-hydroxymethylbenzenesulfonamide	CA2 CA5A	2.48e-05	3	66	2	CID010081162
Drug	6-hydroxy-1,3-benzothiazole-2-sulfonamide	CA2 CA5A	2.48e-05	3	66	2	CID006852129
Drug	4-hydrazinobenzenesulfonamide	CA2 CA5A	2.48e-05	3	66	2	CID000078105
Drug	I7C	CA2 CA5A	2.48e-05	3	66	2	CID000069561
Drug	4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide	CA2 CA5A	2.48e-05	3	66	2	CID000031035
Drug	AC1Q551A	CA2 CA5A	2.48e-05	3	66	2	CID011206245
Drug	AC1NA7ER	CA2 CA5A	2.48e-05	3	66	2	CID004422372
Drug	4-(2-aminoethyl)benzenesulfonamide	CA2 CA5A	2.48e-05	3	66	2	CID000169682
Drug	CTK1B7592	CA2 CA5A	2.48e-05	3	66	2	CID009998322
Drug	4-(2-hydroxyethyl)benzenesulfonamide	CA2 CA5A	2.48e-05	3	66	2	CID010375558
Drug	AC1NQARZ	CA2 CA5A	2.48e-05	3	66	2	CID005172475
Drug	sulpiride (SLP	CA2 CA5A	2.48e-05	3	66	2	CID003018597
Drug	Pro-phe-arg-mca	ME1 F5 ME3	3.44e-05	22	66	3	CID000174085
Drug	hydroxymalonate	ME1 ME2 ME3	3.95e-05	23	66	3	CID000000044
Drug	dichlorphenamide	CA5B CA2 CA5A	3.95e-05	23	66	3	CID000003038
Drug	potassium cyanate	CLSTN2 CA2 CA5A	4.51e-05	24	66	3	CID011378442
Drug	3-Iodosulfanilamide	CA2 CA5A	4.95e-05	4	66	2	CID009861037
Drug	NSC-700707	CA2 CA5A	4.95e-05	4	66	2	CID000134560
Drug	AC1Q511M	CA2 CA5A	4.95e-05	4	66	2	CID004687472
Drug	3-bromosulfanilamide	CA2 CA5A	4.95e-05	4	66	2	CID003526523
Drug	I-7B	CA2 CA5A	4.95e-05	4	66	2	CID000067136
Drug	PB311	CA2 CA5A	4.95e-05	4	66	2	CID001502014
Drug	methazolamide	CA5B CA2 CA5A	5.77e-05	26	66	3	CID000004100
Drug	topiramate	CA5B ME1 CA2 CA5A	7.06e-05	76	66	4	ctd:C052342
Drug	benzolamide	CA5B CA2 CA5A	7.24e-05	28	66	3	CID000018794
Drug	Zinc chromate hydroxide	CLSTN2 CA2 CA5A	8.05e-05	29	66	3	CID000027567
Drug	thiadiazole	KIR3DL1 CA2 CA5A	8.05e-05	29	66	3	CID000067518
Drug	potassium periodate	CA2 CA5A	8.23e-05	5	66	2	ctd:C037192
Drug	sodium metasilicate	CA2 CA5A	8.23e-05	5	66	2	ctd:C025349
Drug	Iodates	CA2 CA5A	8.23e-05	5	66	2	ctd:D007452
Drug	AC1NX069	GP6 CD34 CA2	1.09e-04	32	66	3	CID005716906
Drug	beidellite	CLSTN2 F5	1.23e-04	6	66	2	CID006367228
Drug	EMD 486019	CA2 CA5A	1.23e-04	6	66	2	CID011245700
Drug	orthanilamide	CA2 CA5A	1.23e-04	6	66	2	CID000072894
Drug	2h15	CA2 CA5A	1.23e-04	6	66	2	CID010712038
Drug	triflamide	ODC1 CA2	1.23e-04	6	66	2	CID000079001
Drug	ebrotidine	CA5B CA2 CA5A	1.31e-04	34	66	3	CID000065869
Drug	glyoxylate	ACSS1 PEX5 ME1 ME2 ME3	1.59e-04	176	66	5	CID000000760
Drug	disilane	CLSTN2 KIR3DL1	1.72e-04	7	66	2	CID000074123
Drug	2,3-DHP	MTSS1 ODC1	1.72e-04	7	66	2	CID000000020
Drug	Carbonates	CA2 CA5A	1.72e-04	7	66	2	ctd:D002254
Drug	sulfamic acid	CA2 CA5A	1.72e-04	7	66	2	ctd:C005741
Drug	Nitric Acid	CA2 CA5A	1.72e-04	7	66	2	ctd:D017942
Drug	chloric acid	CA2 CA5A	1.72e-04	7	66	2	ctd:C022842
Drug	bendrofluazide	CA5B CA2 CA5A	1.97e-04	39	66	3	CID000002315
Drug	Dithiol	CLSTN2 ME1 ME2 ME3	2.05e-04	100	66	4	CID000010334
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A	CDK16 SBF1 TTLL5 MINK1 MTSS1	2.06e-04	186	66	5	2426_DN
Drug	Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A	GP6 RND1 MINK1 HABP2 F5	2.06e-04	186	66	5	4163_UP
Drug	Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MPP2 TBC1D13 TTLL5 MINK1 ASTN2	2.06e-04	186	66	5	6051_DN
Drug	Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A	AKAP6 RND1 PTPRD SBF1 HABP2	2.11e-04	187	66	5	5258_UP
Drug	brinzolamide	CA5B CA2 CA5A	2.13e-04	40	66	3	CID000068844
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; PC3; HT_HG-U133A	GP6 RND1 CD34 CA5B CA2	2.16e-04	188	66	5	5733_UP
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A	SBF1 TTLL5 ASTN2 AKAP13 CA5B	2.27e-04	190	66	5	5080_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	MYOF SBF1 ACKR3 PCSK6 ZNF692	2.27e-04	190	66	5	5586_DN
Drug	Bromates	CA2 CA5A	2.29e-04	8	66	2	ctd:D001959
Drug	aminozolamide	CA2 CA5A	2.29e-04	8	66	2	CID000093505
Drug	L-662,583	CA2 CA5A	2.29e-04	8	66	2	CID003082977
Drug	L-643,799	CA2 CA5A	2.29e-04	8	66	2	CID000121595
Drug	sezolamide	CA2 CA5A	2.29e-04	8	66	2	CID000060692
Drug	Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A	GP6 PTPRD PCSK6 MINK1 CA5B	2.38e-04	192	66	5	4151_UP
Drug	Simvastatin [79902-63-9]; Up 200; 9.6uM; PC3; HT_HG-U133A	RND1 TTLL5 MTSS1 AKAP13 ITIH2	2.38e-04	192	66	5	4244_UP
Drug	Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A	GP6 MYOF SBF1 MTSS1 CA5B	2.38e-04	192	66	5	3236_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A	MPP2 MYOF PTPRS AKAP13 PMEL	2.44e-04	193	66	5	4690_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A	CD34 MINK1 AKAP13 HABP2 F5	2.44e-04	193	66	5	4795_UP
Drug	Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MPP2 ZSWIM8 SBF1 PCSK6 ASTN2	2.44e-04	193	66	5	7176_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SBF1 TTLL5 PCSK6 ASTN2 PMEL	2.50e-04	194	66	5	3859_DN
Drug	CP-319743 [172078-87-4]; Down 200; 10uM; PC3; HT_HG-U133A	MINK1 LPIN2 ASTN2 FHIP2B ME3	2.50e-04	194	66	5	7537_DN
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	MPP2 TTLL5 GLRA3 CA5B KHSRP	2.56e-04	195	66	5	3393_DN
Drug	troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA	MPP2 ZSWIM8 RND1 PTPRS MINK1	2.56e-04	195	66	5	1012_UP
Drug	CP-690334-01 [459212-38-5]; Up 200; 1uM; PC3; HT_HG-U133A	ZSWIM8 RND1 CA5B F5 KHSRP	2.56e-04	195	66	5	4561_UP
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	TTLL5 PCSK6 PEX5 CLSTN2 FHIP2B	2.56e-04	195	66	5	2290_DN
Drug	Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MTSS1 CLSTN2 PMEL CDK14 F5	2.56e-04	195	66	5	5474_UP
Drug	rotenone; Up 200; 1uM; MCF7; HT_HG-U133A	TTLL5 PCSK6 MINK1 LPIN2 ITIH2	2.56e-04	195	66	5	5943_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	MYOF SBF1 PTPRS MINK1 ASTN2	2.62e-04	196	66	5	5569_DN
Drug	Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A	PRRX1 CD34 MINK1 ZNF780B CA2	2.62e-04	196	66	5	4484_UP
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; PC3; HT_HG-U133A	MPP2 MYOF SBF1 TTLL5 AKAP13	2.62e-04	196	66	5	2089_DN
Drug	Flecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	RND1 ZNF780B GLRA3 CA5B ITIH2	2.62e-04	196	66	5	3761_UP
Disease	response to anti-tuberculosis drug, drug-induced liver injury	PTPRD ASTN2	1.43e-05	3	65	2	EFO_0004228, EFO_0007918
Disease	inflammatory biomarker measurement	GP6 PCSK6 F5	2.56e-05	26	65	3	EFO_0004872
Disease	central corneal thickness	MYOF MASP1 PRRX1 CD34 AKAP13 HABP2	6.18e-05	309	65	6	EFO_0005213
Disease	Thrombophilia due to thrombin defect	HABP2 F5	1.33e-04	8	65	2	cv:C3160733
Disease	Colorectal Carcinoma	AKAP6 PTPRD PTPRS ACKR3 CLSTN2 ODC1 ADAMTSL3 F5	1.51e-04	702	65	8	C0009402
Disease	Modic type vertebral endplate changes	MPP2 PTPRD	3.67e-04	13	65	2	HP_0030775
Disease	calcium/calmodulin-dependent protein kinase type 1 measurement	PRRX1 F5	5.62e-04	16	65	2	EFO_0008062
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	PCSK6 F5	5.62e-04	16	65	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	migraine without aura, susceptibility to, 4	MPP2 ASTN2	5.62e-04	16	65	2	MONDO_0011847
Disease	androstenedione measurement, estrone measurement	PTPRD CDK14	7.15e-04	18	65	2	EFO_0007970, EFO_0007972
Disease	caudal middle frontal gyrus volume measurement	ASTN2 KHSRP	7.15e-04	18	65	2	EFO_0010290
Disease	glucose homeostasis measurement, acute insulin response measurement	SDK2 ASTN2	7.15e-04	18	65	2	EFO_0006831, EFO_0006896
Disease	gestational age, birth measurement	RND3 PTPRD	9.77e-04	21	65	2	EFO_0005112, EFO_0006921
Disease	malaria (is_implicated_in)	KIR3DL1 KIR3DS1	1.28e-03	24	65	2	DOID:12365 (is_implicated_in)
Disease	Myopia	AKAP6 MPP2 PTPRD AKAP13 MGAT4C	1.60e-03	385	65	5	HP_0000545
Disease	azoospermia (implicated_via_orthology)	PTPRD PTPRS	1.62e-03	27	65	2	DOID:14227 (implicated_via_orthology)
Disease	hepatitis C (is_implicated_in)	KIR3DL1 KIR3DS1	1.74e-03	28	65	2	DOID:1883 (is_implicated_in)
Disease	tuberculosis (is_implicated_in)	KIR3DL1 KIR3DS1	1.74e-03	28	65	2	DOID:399 (is_implicated_in)
Disease	1,5 anhydroglucitol measurement	PMEL MGAM2	1.87e-03	29	65	2	EFO_0008009
Disease	cardiac arrhythmia	AKAP6 PRRX1	2.00e-03	30	65	2	EFO_0004269

Protein segments in the cluster

Peptide	Gene	Start	Entry
ESTPVYPNAGRYWET	ACSS1	361	Q9NUB1
DYWTYSGSLTTPPLS	CA5B	226	Q9Y2D0
EPDSWSSLSYEIPYG	AKAP13	226	Q12802
WYRPPDVLLGSTEYS	CDK14	296	O94921
DGATYEPYLVTNDWP	CLSTN2	471	Q9H4D0
TSTLILPPEYSSWGY	ARRDC1	396	Q8N5I2
QSEGPWPYTTLERGY	ASTN2	556	O75129
WNDPRLAYSEYPDDS	GLRA3	101	O75311
YPTAWVEGSSPDSDL	OFD1	611	O75665
EVESYDPYTDSWTPV	KLHL30	391	Q0D2K2
YSSVDEYFWGKPPST	MGAT4C	361	Q9UBM8
YDEVERTYPPSGAWG	NPHS1	1176	O60500
STDYDQILPDCYSWP	ME1	546	P48163
PDATWYDYETGVAIS	MGAM2	731	Q2M2H8
YYGSKVVPDSTPSWA	ITIH2	656	P19823
SRASYYEISVDDGPW	NADK2	286	Q4G0N4
SFRHSPYEWSDPSDP	KIR3DL1	296	P43629
YSFSSRDPYLWSAPS	GP6	181	Q9HCN6
PNYIDIYSASWGPDD	PCSK6	296	P29122
YVAWGSPEPESYEDT	FHIP2B	481	Q86V87
DLKGSDYSWSYQTPP	MTSS1	246	O43312
PEGTATDRWYDEYHP	PEX5	176	P50542
YSSAGWSEPSDPLEL	LILRA6	101	Q6PI73
MWDPDRYGTTVPYTS	MPP2	396	Q14168
ENPEYFPRGSSYWDR	MIEF1	236	Q9NQG6
EDVYGPDTYPSDWSE	CRLF2	191	Q9HC73
YTEETLAEGPPYDWE	SBF1	1596	O95248
TWDSGNPDPVSYYVI	PTPRS	351	Q13332
DYWTYAGSLTTPPLT	CA5A	226	P35218
ESLDPDWTPDQYDYS	HABP2	31	Q14520
WYRPPDILLGSTDYS	CDK16	326	Q00536
FDYSEPGNFSDISWP	ACKR3	6	P25106
YPDSYPSDSEVTWNI	MASP1	36	P48740
EYDSLLPDVYEWPES	ME2	561	P23368
TPDYDSFTLDSYTWP	ME3	581	Q16798
SWEPGSDGLSPVRYY	SDK2	1421	Q58EX2
SWSPTGERLGEDPYY	CD34	316	P28906
PDEKYYSSSIWGPTC	ODC1	346	P11926
LTWDSGNPEPVSYYI	PTPRD	341	P23468
IELSLWDTSGSPYYD	RND3	71	P61587
WDTSGSPYYDNVRPL	RND3	76	P61587
PDATYDYRSDIWSLG	MINK1	206	Q8N4C8
PPTGQSDYTKAWEEY	KHSRP	611	Q92945
SATPAKPTDGLYTYW	TRIM42	561	Q8IWZ5
TLSVGPESSWPYKEY	TDRD15	736	B5MCY1
REYTYEWSISEDSGP	F5	146	P12259
VELSLWDTSGSPYYD	RND1	61	Q92730
WDTSGSPYYDNVRPL	RND1	66	Q92730
SFRHSPYEWSDPSDP	KIR3DS1	296	Q14943
DPSGYLAEADLSYTW	PMEL	246	P40967
VEAWYGSDEYLALPS	AKAP6	621	Q13023
ESLDYWTYPGSLTTP	CA2	186	P00918
IYTSLQWDSPAPDTY	CLEC9A	6	Q6UXN8
SYDYWLGLSPEEDST	CLEC12A	186	Q5QGZ9
FPVSGDLESNPDYWS	ILDR2	361	Q71H61
KAAEDSPYWVSPAYS	WDR70	611	Q9NW82
GPLYYTFATDPNSEW	TBC1D13	236	Q9NVG8
PYTWSYPEIDKDFES	TBCC	291	Q15814
YTDFDGTRVYSPPEW	PIM3	201	Q86V86
ETSRWYPDLESKYGP	ZNF780B	71	Q9Y6R6
EAVWPYFYTGTDSEP	TRIM60	446	Q495X7
WEEAYPLPGVTYSGT	ZSWIM8	486	A7E2V4
RPTDYLSWGTASPYS	PRRX1	186	P54821
LSYPRDGWDESTAAY	SIGLEC11	56	Q96RL6
FPTSETWEIYGSYLE	TTLL5	486	Q6EMB2
LWTYSSSPDDSEPDA	ZNF692	211	Q9BU19
IPLPEDSETTYDWEY	ADAMTSL3	636	P82987
YPLSDGDWSPLETTY	LPIN2	221	Q92539
YPGGDWKPAEDTYTD	MYOF	941	Q9NZM1